
Opinion|Videos|September 27, 2024
Role of PDE-4 in the Management of Plaque Psoriasis
Author(s)E. James Song, MD, FAAD
Focusing on treatment paradigms in plaque psoriasis, E. James Song, MD, FAAD, provides insights on phosphodiesterase inhibitors 4 (PDE-4) and their role in the therapeutic landscape.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
New Review Confirms How Nonmedicated Skin Care Vehicles Drive Clinical Improvement
2
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
3
Dermatology Times Spot Test: July 19, 2026
4
Soficitinib (ICP-332) Meets Primary Endpoint in Phase 3 Trial for Moderate to Severe AD
5












